Rare Does Not Mean Worthless: How Rare Diseases Have Shaped Neurodevelopment Research in the NGS Era

The advent of next-generation sequencing (NGS) is heavily changing both the diagnosis of human conditions and basic biological research. It is now possible to dig deep inside the genome of hundreds of thousands or even millions of people and find both common and rare genomic variants and to perform...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mattia Zaghi, Federica Banfi, Edoardo Bellini, Alessandro Sessa
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/ee5e365aab4148eb825b97321157f28e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ee5e365aab4148eb825b97321157f28e
record_format dspace
spelling oai:doaj.org-article:ee5e365aab4148eb825b97321157f28e2021-11-25T16:54:10ZRare Does Not Mean Worthless: How Rare Diseases Have Shaped Neurodevelopment Research in the NGS Era10.3390/biom111117132218-273Xhttps://doaj.org/article/ee5e365aab4148eb825b97321157f28e2021-11-01T00:00:00Zhttps://www.mdpi.com/2218-273X/11/11/1713https://doaj.org/toc/2218-273XThe advent of next-generation sequencing (NGS) is heavily changing both the diagnosis of human conditions and basic biological research. It is now possible to dig deep inside the genome of hundreds of thousands or even millions of people and find both common and rare genomic variants and to perform detailed phenotypic characterizations of both physiological organs and experimental models. Recent years have seen the introduction of multiple techniques using NGS to profile transcription, DNA and chromatin modifications, protein binding, etc., that are now allowing us to profile cells in bulk or even at a single-cell level. Although rare and ultra-rare diseases only affect a few people, each of these diseases represent scholarly cases from which a great deal can be learned about the pathological and physiological function of genes, pathways, and mechanisms. Therefore, for rare diseases, state-of-the-art investigations using NGS have double valence: their genomic cause (new variants) and the characterize the underlining the mechanisms associated with them (discovery of gene function) can be found. In a non-exhaustive manner, this review will outline the main usage of NGS-based techniques for the diagnosis and characterization of neurodevelopmental disorders (NDDs), under whose umbrella many rare and ultra-rare diseases fall.Mattia ZaghiFederica BanfiEdoardo BelliniAlessandro SessaMDPI AGarticlenext-generation sequencing (NGS)neurodevelopmental disorders (NDDs)diagnosisexperimental modellinggene functionMicrobiologyQR1-502ENBiomolecules, Vol 11, Iss 1713, p 1713 (2021)
institution DOAJ
collection DOAJ
language EN
topic next-generation sequencing (NGS)
neurodevelopmental disorders (NDDs)
diagnosis
experimental modelling
gene function
Microbiology
QR1-502
spellingShingle next-generation sequencing (NGS)
neurodevelopmental disorders (NDDs)
diagnosis
experimental modelling
gene function
Microbiology
QR1-502
Mattia Zaghi
Federica Banfi
Edoardo Bellini
Alessandro Sessa
Rare Does Not Mean Worthless: How Rare Diseases Have Shaped Neurodevelopment Research in the NGS Era
description The advent of next-generation sequencing (NGS) is heavily changing both the diagnosis of human conditions and basic biological research. It is now possible to dig deep inside the genome of hundreds of thousands or even millions of people and find both common and rare genomic variants and to perform detailed phenotypic characterizations of both physiological organs and experimental models. Recent years have seen the introduction of multiple techniques using NGS to profile transcription, DNA and chromatin modifications, protein binding, etc., that are now allowing us to profile cells in bulk or even at a single-cell level. Although rare and ultra-rare diseases only affect a few people, each of these diseases represent scholarly cases from which a great deal can be learned about the pathological and physiological function of genes, pathways, and mechanisms. Therefore, for rare diseases, state-of-the-art investigations using NGS have double valence: their genomic cause (new variants) and the characterize the underlining the mechanisms associated with them (discovery of gene function) can be found. In a non-exhaustive manner, this review will outline the main usage of NGS-based techniques for the diagnosis and characterization of neurodevelopmental disorders (NDDs), under whose umbrella many rare and ultra-rare diseases fall.
format article
author Mattia Zaghi
Federica Banfi
Edoardo Bellini
Alessandro Sessa
author_facet Mattia Zaghi
Federica Banfi
Edoardo Bellini
Alessandro Sessa
author_sort Mattia Zaghi
title Rare Does Not Mean Worthless: How Rare Diseases Have Shaped Neurodevelopment Research in the NGS Era
title_short Rare Does Not Mean Worthless: How Rare Diseases Have Shaped Neurodevelopment Research in the NGS Era
title_full Rare Does Not Mean Worthless: How Rare Diseases Have Shaped Neurodevelopment Research in the NGS Era
title_fullStr Rare Does Not Mean Worthless: How Rare Diseases Have Shaped Neurodevelopment Research in the NGS Era
title_full_unstemmed Rare Does Not Mean Worthless: How Rare Diseases Have Shaped Neurodevelopment Research in the NGS Era
title_sort rare does not mean worthless: how rare diseases have shaped neurodevelopment research in the ngs era
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/ee5e365aab4148eb825b97321157f28e
work_keys_str_mv AT mattiazaghi raredoesnotmeanworthlesshowrarediseaseshaveshapedneurodevelopmentresearchinthengsera
AT federicabanfi raredoesnotmeanworthlesshowrarediseaseshaveshapedneurodevelopmentresearchinthengsera
AT edoardobellini raredoesnotmeanworthlesshowrarediseaseshaveshapedneurodevelopmentresearchinthengsera
AT alessandrosessa raredoesnotmeanworthlesshowrarediseaseshaveshapedneurodevelopmentresearchinthengsera
_version_ 1718412871961935872